These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7373025)

  • 1. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.
    Doenhoff M; Bickle Q; Bain J; Webbe G; Nelson G
    J Helminthol; 1980 Mar; 54(1):7-16. PubMed ID: 7373025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of schistosomiasis mansoni].
    de Carvalho SA
    Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
    [No Abstract]   [Full Text] [Related]  

  • 3. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy of Schistosomiasis mansoni.
    Katz N
    Adv Pharmacol Chemother; 1977; 14():1-70. PubMed ID: 18911
    [No Abstract]   [Full Text] [Related]  

  • 7. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to chemotherapeutic agents of strains of Schistosoma mansoni isolated from treated and untreated patients.
    Araujo N; Katz N; Pinto Dias E; de Souza CP
    Am J Trop Med Hyg; 1980 Sep; 29(5):890-4. PubMed ID: 7435791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotherapy of schistosomiasis.
    Archer S
    Annu Rev Pharmacol Toxicol; 1985; 25():485-508. PubMed ID: 3890709
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of schistosomiasis in man (a review of the literature)].
    Iarotskiĭ LS
    Med Parazitol (Mosk); 1975; 44(3):351-9. PubMed ID: 1101015
    [No Abstract]   [Full Text] [Related]  

  • 14. The immune-dependence of chemotherapy in experimental schistosomiasis.
    Doenhoff MJ
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():31-7. PubMed ID: 2517867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
    Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni: an in vivo study of drug-induced autophagy in the gastrodermis.
    Clarkson J; Erasmus DA
    J Helminthol; 1984 Mar; 58(1):59-68. PubMed ID: 6325532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune-dependence of schistosomicidal chemotherapy: relative lack of efficacy of an antimonial in Schistosoma mansoni-infected mice deprived of their T-cells and the demonstration of drug-antiserum synergy.
    Doenhoff MJ; Bain J
    Clin Exp Immunol; 1978 Aug; 33(2):232-8. PubMed ID: 309809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically available antischistosomal drugs.
    Davis A
    J Toxicol Environ Health; 1975 Nov; 1(2):191-201. PubMed ID: 1206768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.